UPGD Invesco Bloomberg Analyst Rating Improvers ETF

Expense Ratio
0.4%
Dividend
1.76%
Previous close
$73.47
Est. 12 months change
+19.16%
Projected Price
$87.54

Profitability Metrics

Return on Equity (ROE)
41.25%
Return on Assets (ROA)
8.31%
Return on Invested Capital (ROIC)
26.60%
Weighted Average Cost of Capital (WACC)
9.53%
ROIC - WACC
17.08%
Updated : 2026-04-03 19:21 ET

Valuation Metrics

P/E Ratio
22.92
Forward P/E
18.12
PEG Ratio
2.41
Debt Current Ratio
1.81

Growth & Cash Flow

Gross Margin
48.40%
Operating Margin
9.74%
FCF Margin
16.42%
TTM Revenue Growth
8.64%
Projected 12M EPS Growth
26.44%

Price Change

Price % from 50 SMA
-3.91%
Price % from 200 SMA
-1.44%
6 Months
-2.92%
1 Year
4.28%
2 Years
12.02%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
NA3.22%
CAT2.65%
NET2.53%
PLTR2.48%
CHRW2.46%
IBM2.45%
FICO2.38%
ZM2.34%
WAT2.28%
CMI2.13%

ETF Analysis

Fund Overview

Invesco Bloomberg Analyst Rating Improvers ETF (UPGD) currently reports 51 stock positions (subject to change), placing it in the moderately diversified range by holdings breadth. The top line-up is NA (3.22%), CAT (2.65%), NET (2.53%), with NA as the largest single weight at 3.22%. Together, the top three holdings account for 8.40%, which indicates that performance drivers are distributed more evenly across the broader basket. This architecture allows the fund to express a clear investment thesis at the top while relying on the broader basket to manage idiosyncratic volatility.

Profitability & Capital Efficiency

From a capital efficiency perspective, ROIC is 26.60%, WACC is 9.53%, and the economic spread is 17.08%. On balance, holdings generate meaningful returns above their cost of capital, a hallmark of competitively advantaged businesses. Supporting metrics show ROE at 41.25% and ROA at 8.31%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

Turning to how the market is pricing the underlying earnings, trailing P/E of 22.92, forward P/E of 18.12, PEG of 2.41. Trailing and forward valuations are closely aligned, pointing to a market that is pricing continuity rather than improvement in the earnings outlook. A PEG in this range suggests valuation is fair rather than compelling — the portfolio is priced adequately for its growth, with limited buffer for downside revisions. At 1.81, the aggregate current ratio indicates adequate but not exceptional balance sheet coverage. The combined picture across P/E, forward P/E, PEG, and current ratio suggests a portfolio that is priced for continued execution — where disappointment would be costly and outperformance would likely require positive earnings surprises.

Margins & Cash Generation

On the margin front: gross margin sits at 48.40%, operating margin at 9.74%, and free cash flow margin at 16.42%. At this level, the portfolio reflects reasonable cost discipline and adequate pricing leverage at the production layer. The operating margin reading is below average, pointing to businesses where scaling costs remain a challenge. Strong free cash flow margins point to businesses with meaningful financial flexibility and limited dependence on external capital. The margin stack is not uniformly strong, which means the portfolio's earnings resilience under adverse conditions is less certain.

Growth & Forward Outlook

On the forward picture: TTM revenue growth of 8.64% reflecting consistent if unspectacular revenue expansion. Consensus EPS estimates point to 26.4% earnings growth over the next 12 months — a compelling near-term earnings catalyst that, if delivered, changes the valuation conversation materially. Analyst price targets suggest street expectations imply a constructive but measured return profile on a 12-month view. Revenue growth is grounded in reported results; price targets are forward projections that embed assumptions about multiple expansion, earnings delivery, and macro conditions. The key risk in both directions is whether the underlying businesses can maintain their operating trajectory as macro and sector conditions evolve. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Buy

The composite picture leans positive, with capital efficiency and growth momentum providing the core of the investment thesis.

This assessment reflects quantitative metrics only and does not constitute financial advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.